These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3139576)

  • 1. Effect of PSK, a protein-bound polysaccharide from Coriolus versicolor, on drug-metabolizing enzymes in sarcoma-180 bearing and normal mice.
    Fujita H; Ogawa K; Ikuzawa M; Muto S; Matsuki M; Nakajima S; Shimamura M; Togawa M; Yoshikumi C; Kawai Y
    Int J Immunopharmacol; 1988; 10(4):445-50. PubMed ID: 3139576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of krestin (PSK) on drug-metabolizing enzymes with special reference to the activation of FT-207].
    Fujita H; Ogawa K; Ikuzawa M; Muto S; Matsuki M; Nakajima S; Shimamura M; Togawa M; Yoshikumi C; Kawai Y
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2653-7. PubMed ID: 3090941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein-bound polysaccharide immunomodulator, PSK, does not suppress the conversion from 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in patients with gastric cancer.
    Anai H; Sakaguchi Y; Emi Y; Kohnoe S; Maehara Y; Sugimachi K
    Anticancer Drugs; 1991 Jun; 2(3):275-8. PubMed ID: 1802023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.
    Farquhar D; Benvenuto JA; Kuttesch N; Loo TL
    Biochem Pharmacol; 1983 Apr; 32(7):1275-80. PubMed ID: 6847717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of immunopotentiators on the activation of 5-FU derivatives].
    Nakazato H; Kito T; Yasue M; Yamamura Y; Kobari T; Hirakawa T; Hatta M
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):867-74. PubMed ID: 3920971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of PSK on the metabolism of FT-207].
    Maehara Y; Tamada R; Miyahara M; Notsuka T; Kano T; Kumashiro R; Inokuchi K
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1843-7. PubMed ID: 6433806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antitumor agents from various natural sources on drug-metabolizing system, phagocytic activity and complement system in sarcoma 180-bearing mice.
    Ito H
    Jpn J Pharmacol; 1986 Mar; 40(3):435-43. PubMed ID: 3712870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of biological response modifiers with different modes of action used separately and together on immune responses in mice with syngeneic tumours.
    Matsunaga K; Morita I; Iijima H; Endoh H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
    J Int Med Res; 1992 Sep; 20(5):406-21. PubMed ID: 1280606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK.
    Suo J; Tanaka N; Hizuta A; Yunoki S; Orita K
    Acta Med Okayama; 1994 Oct; 48(5):237-42. PubMed ID: 7863794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3468-75. PubMed ID: 3789758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Competitive effect of PSK against the immunosuppressive effect induced in the sera of mice bearing syngeneic tumors].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3461-7. PubMed ID: 3789757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK.
    Kanoh T; Matsunaga K; Saito K; Fujii T
    In Vivo; 1994; 8(2):247-50. PubMed ID: 7522606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3453-60. PubMed ID: 3789756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK.
    Matsunaga K; Iijima H; Aota M; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1992 Jan; 37(1):21-37. PubMed ID: 1339233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies to increase the antitumor activity of 1-(tetrahydro-2-furanyl)-5-fluorouracil and its metabolic aspects by combined administration with L-cysteine.
    Kawabata N; Sugiyama S; Kuwamura T; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1983 Aug; 33(4):735-47. PubMed ID: 6415326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a biological response modifier, PSK, on intestinal flora of tumor-bearing mice.
    Sakurai K; Motokawa I; Ando T; Ohmura Y; Saito K; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    In Vivo; 1993; 7(2):175-9. PubMed ID: 8364170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum.
    Soyka LF; Stephens CC; MacPherson BR; Foster RS
    Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of PSK, an antitumor protein-bound polysaccharides, by thymocyte electrophoresis.
    Iwaguchi T; Mori T; Kohsaki G
    J Pharmacobiodyn; 1984 Sep; 7(9):677-80. PubMed ID: 6441839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression of hepatic biotransformations by chemical immunoadjuvants.
    Giampietri A; Puccetti P; Contessa AR
    J Immunopharmacol; 1981; 3(2):251-64. PubMed ID: 7338632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.